Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSL2500084	Mosunetuzumab Injection (Subcutaneous Injection)	mosunetuzumab	Injection	Biological Products(2.1)	Import Drug Application	2025-05-30	F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd	view
JXSL2500023	Mosunetuzumab Injection (Subcutaneous Injection)	mosunetuzumab	Injection	Biological Products(2.1)	Import Drug Application	2025-02-12	F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd	view
JXSB2500025	Mosunetuzumab Injection (Subcutaneous Injection)	mosunetuzumab	Injection	Biological Products	Supplementary Application	2025-03-27	Genentech Inc;F Hoffmann-La Roche Ltd(Switzerland)	view
JXSB2500026	Mosunetuzumab Injection (Subcutaneous Injection)	mosunetuzumab	Injection	Biological Products	Supplementary Application	2025-03-27	Genentech Inc;F Hoffmann-La Roche Ltd(Switzerland)	view
JXSL2500083	Mosunetuzumab Injection (Subcutaneous Injection)	mosunetuzumab	Injection	Biological Products(2.1)	Import Drug Application	2025-05-30	F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd	view
JXSL2500024	Mosunetuzumab Injection (Subcutaneous Injection)	mosunetuzumab	Injection	Biological Products(2.1)	Import Drug Application	2025-02-12	F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd	view